Your browser doesn't support javascript.
loading
Causes of liver injury in patients with COVID-19 and treatment with hepatoprotective drugs / 药学实践杂志
Journal of Pharmaceutical Practice ; (6): 481-484, 2020.
Article in Chinese | WPRIM | ID: wpr-829948
ABSTRACT
COVID-19 patients infected with SARS-CoV-2 showed different degrees of liver injury. A series of studies have shown that cytokine storm, bile duct cell injury caused by SARS-CoV-2 and drug-induced hepatotoxicity can induce secondary liver injury. This article will review the mechanism of liver injury caused by different factors and the treatment of hepatoprotective drugs, in order to provide reference support for further research in this field.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Etiology study Language: Chinese Journal: Journal of Pharmaceutical Practice Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Etiology study Language: Chinese Journal: Journal of Pharmaceutical Practice Year: 2020 Type: Article